A study of Epstein-Barr virus infections in heart and heart and lung transplant recipients.
Wreghitt
T G
TG
Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Cambridge, England.
Sargaison
M
M
Sutehall
G
G
Woodward
C G
CG
Scott
J
J
English
T A
TA
Wallwork
J
J
D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000096:biosynthesis; D000956:Antigens, Viral / Q000276:immunology; D036022:Capsid Proteins; D002648:Child; D016027:Heart Transplantation; D016041:Heart-Lung Transplantation; D006566:Herpesviridae Infections / Q000209:etiology* / Q000382:microbiology; D004854:Herpesvirus 4, Human; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis; D007075:Immunoglobulin M / Q000096:biosynthesis; D016040:Lung Transplantation; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology
D000914:Antibodies, Viral; D000956:Antigens, Viral; D036022:Capsid Proteins; C041788:Epstein-Barr viral capsid antigen; D007074:Immunoglobulin G; D007075:Immunoglobulin M